IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that its AI-enabled Clinical Decision Support Tool, developed in collaboration with Breakthrough T1D, has won the 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year.
Powered by IQVIA Healthcare-grade AI®, the tool tackles a long-standing problem in diabetes care: adults with type 1 diabetes (T1D) are often misclassified as having type 2 diabetes (T2D). That mistake delays the right treatment and raises the risk of serious, sometimes life-threatening complications.
Results in practice:
Cut the screening workload by 99.5%, narrowing reviews from about 60,000 patients down to 300, or roughly 200 times fewer chart reviews.
